Large between-patient variability in egfr decline before clinical trial enrollment and impact on atrasentan’s efficacy: a post hoc analysis from the SONAR trial

  1. Waijer, S.W.
  2. de Vries, S.T.
  3. Busch, R.
  4. Xie, D.
  5. Gansevoort, R.T.
  6. Hou, F.F.
  7. Gorriz, J.L.
  8. Laverman, G.D.
  9. de Nicola, L.
  10. Pascual, J.
  11. Provenzano, M.
  12. Pergola, P.E.
  13. Tang, S.C.W.
  14. Wanner, C.
  15. Zaoui, P.
  16. Parving, H.-H.
  17. de Zeeuw, D.
  18. Heerspink, H.J.L.
Zeitschrift:
Journal of the American Society of Nephrology

ISSN: 1533-3450,  1046-6673

Datum der Publikation: 2021

Ausgabe: 32

Nummer: 11

Seiten: 2731-2734

Art: Artikel

DOI: 10.1681/ASN.2021040498 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus